T Rowe Price Group Investing Cash Flow decreased by 76.1% to $59.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 224.7%, from -$47.80M to $59.60M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -40.6% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.50M | $51.90M | -$1.16B | $3.80M | -$29.50M | -$43.80M | -$57.50M | -$78.40M | $174.00M | $90.10M | -$8.60M | -$84.80M | -$61.60M | -$22.50M | -$47.80M | -$9.00M | $37.90M | $249.20M | $59.60M |
| QoQ Change | — | +42.2% | <-999% | +100.3% | -876.3% | -48.5% | -31.3% | -36.3% | +321.9% | -48.2% | -109.5% | -886.0% | +27.4% | +63.5% | -112.4% | +81.2% | +521.1% | +557.5% | -76.1% |
| YoY Change | — | — | — | — | -180.8% | -184.4% | <-999% | -165.8% | +497.3% | — | +85.0% | -8.2% | -135.4% | -125.0% | -455.8% | +89.4% | +161.5% | >999% | +224.7% |